Test Description
The Colony Assay under Japanese MHLW guidelines is a cytotoxicity test used to evaluate the potential of medical devices to cause cell death or inhibit cell growth. This in vitro assay measures the ability of cells to form colonies after exposure to extracts from device materials. It is particularly sensitive and helps identify toxic leachables that may compromise biocompatibility and patient safety.
Why This Testing is Performed
This test is required for medical devices intended for the Japanese market and is part of the biological evaluation process. It helps determine whether materials used in devices release substances that are harmful to living cells. The assay supports regulatory compliance and ensures that devices meet safety standards before clinical use or market approval.
Have you tried our Test Navigator Tool? Try it now
Steps in Conducting This Test
- Preparation of Extracts: Device materials are extracted using appropriate solvents under controlled conditions.
- Cell Seeding: Cells (e.g., V79) are seeded in culture plates and allowed to adhere.
- Exposure: Cells are exposed to various concentrations of the test item extract.
- Incubation: Cultures are incubated to allow colony formation.
- Staining and Counting: Colonies are stained and counted to assess cell viability and proliferation.
- Data Analysis: Results are compared to controls to determine cytotoxic effects.
Standards, Guidance, and Regulations
- ISO 10993-5: Governs in vitro cytotoxicity testing methods.
- Japanese MHLW Guidelines: Specify extraction procedures and assay conditions unique to Japan’s regulatory framework.
- ISO/IEC 17025: Ensures laboratory competence and test reliability.
- GLP Compliance (21 CFR Part 58): Required for regulatory submissions to ensure data integrity.
| Test Code |
|---|
| V0035-100 |